The Safety and Efficacy of the Repeated PRRT with [⁹⁰Y]Y/[¹⁷⁷Lu]Lu-DOTATATE in Patients with NET

Table 1

Patient characteristics.

Characteristic	PRRT (n = 26)	R-PRRT (n = 26)	RR-PRRT (n = 5)
Age (in years), mean (range)	52 (30–72)	55 (34–77)	61 (37–75)
Sex
Male	6	6	2
Female	20	20	3
Primary tumour site
Pancreas	11	11	2
Small intestine	5	5	—
Large intestine	8	8	2
Lung	1	1	—
Unknown	1	1	1
Grade
1	9	9	1
2	17	17	4